New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 25, 2014
07:07 EDTINSYInsys receives FDA orphan drug designation for pharmaceutical cannabidiol
Insys Therapeutics announced that the U.S. Food and Drug Administration has granted orphan drug designation to its pharmaceutical cannabidiol for the treatment of Lennox-Gastaut Syndrome, a rare pediatric-onset epilepsy. The company said, "We have the unique opportunity to test a controlled pharmaceutical CBD product for Lennox-Gastaut Syndrome, and our company is committed to advancing cannabinoid therapies that have the potential to provide significant medical benefits to patients across multiple indications. We expect to file an Investigational New Drug Application for CBD in 2H14."
News For INSY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
April 24, 2015
15:09 EDTINSYInsys falls after SIRF links drug to 'growing number' of deaths
Subscribe for More Information
April 23, 2015
07:17 EDTINSYInsys Therapeutics commences dosing in Phase 1/2 study of CBD oral solution
Subscribe for More Information
April 17, 2015
10:07 EDTINSYHigh option volume stocks
Subscribe for More Information
April 14, 2015
14:47 EDTINSYInsys Therapeutics management to meet with Jefferies
Meetings to be held in Denver/San Francisco on April 16-17 hosted by Jefferies.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use